Frontiers in Bioengineering and Biotechnology · 2023 · 25 citations · 31 references
PharmacyOncologyPharmaceuticsApoptosisDrug DeliveryGene DeliveryApoptosis In CancerApoptosis ResistanceCancer Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomedicineApoptosis TargetingDrug Delivery NanocarriersGene Delivery NanocarriersGene Delivery NanomaterialsGene Delivery NanoparticlesGene-targeted TherapyTargeted Gene TherapyTherapeutic Resistance Mechanisms
Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths worldwide, with resistance to apoptosis being a major driver of therapeutic resistance and aggressive phenotype. This study aimed to develop a novel gene therapy approach for NSCLC by targeting resistance to apoptosis. Loss of function mutations of caspase 8 (CASP8) and downregulation of microRNAs (miRs) 29A-B1 and 34A were identified as key contributors to resistance to apoptosis in NSCLC. A biodegradable polymeric nano-gene delivery system composed of chitosan-poly-lactic-co-glycolic acid was formulated to deliver initiator CASP8 and miRs 29A-B1 and 34A. The nano-formulation efficiently encapsulated the therapeutic genes effectively internalized into NSCLC cells and induced significant apoptosis. Evaluation of the nano-formulation in A549 tumor spheroids showed a significant increase in apoptosis within the core of the spheroids, suggesting effective penetration into the spheroid structures. We provide a novel nano-formulation that demonstrate therapeutic potential for suicidal gene therapy in NSCLC.
31
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich, Claudia Seidel, Reinhard Ebner et al. · Nature Protocols · 2009 · 1.7K citations
mir-29 regulates Mcl-1 protein expression and apoptosis
Justin L. Mott, Shogo Kobayashi, Steven F. Bronk et al. · Oncogene · 2007 · 829 citations · Full text